← Leaderboards
Manal F. Abdelmalek
University Of Florida
$1,514,311
Attributed
$2,257,048
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $382.5K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,257,048 · 8
By mechanism
R01$913,910 · 1
K23$618,030 · 1
U01$571,565 · 1
M01$153,543 · 5
Top collaborators
- Brian J Soher3 shared
- Anna Mae Elizabeth Diehl2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Phillip P Toskes$1,841,794
- Brad H. Pollock$62,738,731
- Bhavana Patel$857,616
- Folakemi T Odedina$5,176,812
- Ammon B Peck$4,831,038
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverLiver DiseasesObesityHepaticMetabolicMorbidity - Disease RateUnited States National Institutes Of HealthMultidisciplinaryMetabolismInsulin ResistanceNon-Alcoholic Fatty LiverPreventSafetyPublic Health Medicine (Field)PrevalenceRandomizedChronicMeasurementEnzymesHepatocyteFundingFibrosisHistologicMortality Vital Statistics
Grant awards (16)
Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis$189,022
U01 · FY2022 · DK
Prediction and Prevention of Hepatic Decompensation in Patients with Cirrhosis$382,543
U01 · FY2021 · DK
Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD$314,000
R01 · FY2014 · DK
Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD$303,010
R01 · FY2013 · DK
Impact of Fructose on Metabolism, Energy Homeostasis and MR biomarkers in NAFLD$296,900
R01 · FY2012 · DK
Hyperinsulinemia and Insulin Resistance in Fatty Liver$123,390
K23 · FY2009 · DK · contact PI
Hyperinsulinemia and Insulin Resistance in Fatty Liver$123,390
K23 · FY2008 · DK · contact PI
Hyperinsulinemia and Insulin Resistance in Fatty Liver$123,390
K23 · FY2007 · DK · contact PI
TRIAL OF BETAINE IN PTS WITH NONALCOHOLIC STEATOHEPATIS$5,897
M01 · FY2007 · RR · contact PI
INSULIN RESISTANCE IN NONALCOHOLIC FATTY LIVER DISEASE A CASE CONTROL STUDY$3,751
M01 · FY2007 · RR · contact PI
Hyperinsulinemia and Insulin Resistance in Fatty Liver$124,470
K23 · FY2006 · DK · contact PI
INSULIN RESISTANCE IN NONALCOHOLIC FATTY LIVER DISEASE A CASE CONTROL STUDY$16,504
M01 · FY2006 · RR · contact PI
TRIAL OF BETAINE IN PTS WITH NONALCOHOLIC STEATOHEPATIS$13,204
M01 · FY2006 · RR · contact PI
Hyperinsulinemia and Insulin Resistance in Fatty Liver$123,390
K23 · FY2005 · DK
TRIAL OF BETAINE IN PTS WITH NONALCOHOLIC STEATOHEPATIS$50,682
M01 · FY2005 · RR
Trial of Betaine In Pts with Nonalcoholic Steatohepatitis$63,505
M01 · FY2004 · RR